Patents by Inventor Magnus Munck Af Rosenschold

Magnus Munck Af Rosenschold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Hydantoin Derivatives as Metalloproteinase Inhibitors
    Publication number: 20080293743
    Abstract: The invention provides compounds of formula (I): wherein R1, R2, A, A1 and B are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inhibitors.
    Type: Application
    Filed: December 14, 2005
    Publication date: November 27, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Balint Gabos, Michael Lundkvist, Magnus Munck Af Rosenschold, Igor Shamovsky, Pavol Zlatoidsky
  • Metalloproteinase Inhibitors
    Publication number: 20080262045
    Abstract: Compounds of the formula (I) wherein Z is SO2(N6) or N(R7)SO2 or N(R7)SO2N(R6) useful as metalloproteinase inhibitors, especially as inhibitors of MMP12.
    Type: Application
    Filed: May 5, 2008
    Publication date: October 23, 2008
    Inventors: Anders Eriksson, Matti Lepisto, Michael Lundkvist, Magnus Munck Af Rosenschold, Pavol Zlatoidsky
  • Metalloproteinase inhibitors
    Patent number: 7427631
    Abstract: Compounds of the formula (I) wherein z is SO2 or SO, useful as metalloproteinase inhibitors, especially as inhibitors of MMP12.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: September 23, 2008
    Assignee: AstraZeneca AB
    Inventors: Anders Eriksson, Matti Lepistö, Michael Lundkvist, Magnus Munck Af Rosenschöld, Pavol Zlatoidsky
  • Novel Compounds
    Publication number: 20080221139
    Abstract: The invention provides compounds of formula (I): wherein R1 and R2 are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inhibitors.
    Type: Application
    Filed: November 28, 2007
    Publication date: September 11, 2008
    Inventors: David Chapman, Balint Gabos, Magnus Munck af Rosenschold
  • Chemical compounds 572
    Publication number: 20080214641
    Abstract: Compounds of formula (I): The present invention relates to novel indazolyl ester or amide derivatives, to pharmaceutical compositions comprising such derivatives, to processes for preparing such novel derivatives and to the use of such derivatives as medicaments
    Type: Application
    Filed: December 20, 2007
    Publication date: September 4, 2008
    Inventors: Markus Berger, Jan Dahmen, Karl Edman, Anders Eriksson, Balint Gabos, Thomas Hansson, Martin Hemmerling, Krister Henriksson, Svetlana Ivanova, Matti Lepisto, Darren McKerrecher, Magnus Munck af Rosenschold, Stinabritt Nilsson, Hartmut Rehwinkel, Camilla Taflin
  • Metalloproteinase inhibitors
    Patent number: 7368465
    Abstract: Compounds of the formula (I) wherein Z is SO2(N6) or N(R7)SO2 or N(R7)SO2N(R6) useful as metalloproteinase inhibitors, especially as inhibitors of MMP12.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: May 6, 2008
    Assignee: AstraZeneca AB
    Inventors: Anders Eriksson, Matti Lepistö, Michael Lundkvist, Magnus Munck Af Rosenschöld, Pavol Zlatoidsky
  • 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12
    Patent number: 7354940
    Abstract: The invention provides compounds of formula (I) in which L, X, Y, Z1, Z2, R1, R2, R3 and G2 have the meanings defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds of the invention are inhibitors of metalloproteinase MMP12 and are among other things useful for the treatment of obstructive airways diseases, such as asthma and chronic obstructive pulmonary disease (COPD).
    Type: Grant
    Filed: August 26, 2003
    Date of Patent: April 8, 2008
    Assignee: AstraZeneca AB
    Inventors: Krister Henriksson, Magnus Munck Af Rosenschöld
  • Metalloproteinase inhibitors
    Patent number: 7132434
    Abstract: Compounds of the formula (I), useful as metal-loproteinase inhibitors, especially as inhibitors of MMP12
    Type: Grant
    Filed: November 6, 2002
    Date of Patent: November 7, 2006
    Assignee: AstraZeneca AB
    Inventors: Anders Eriksson, Matti Lepistö, Michael Lundkvist, Magnus Munck Af Rosenschöld, Kristina Stenvall, Pavol Zlatoidsky
  • Novel metalloproteinase ihibitors
    Publication number: 20050026990
    Abstract: Compounds of the formula (I), useful as metal-loproteinase inhibitors, especially as inhibitors of MMP12.
    Type: Application
    Filed: November 6, 2002
    Publication date: February 3, 2005
    Inventors: Anders Eriksson, Matti Lepisto, Michael Lundkvist, Magnus Munck Af Rosenschold, Kristina Stenvall, Pavol Zlatoidsky
  • Metalloproteinase inhibitors
    Publication number: 20040138276
    Abstract: Compounds of the formula (I) wherein Z is SO2(N6) or N(R7)SO2 or N(R7)SO2N(R6) useful as metalloproteinase inhibitors, especially as inhibitors of MMP12.
    Type: Application
    Filed: September 12, 2003
    Publication date: July 15, 2004
    Inventors: Anders Eriksson, Matti Lepisto, Michael Lundkvist, Magnus Munck Af Rosenschold, Pavol Zlatoidsky
  • Metalloproteinase inhibitors
    Publication number: 20040127528
    Abstract: Compounds of the formula (I) wherein z is SO2 or SO, useful as metalloproteinase inhibitors, especially as inhibitors of MMP12.
    Type: Application
    Filed: January 14, 2004
    Publication date: July 1, 2004
    Inventors: Anders Eriksson, Matti Lepisto, Michael Lundkvist, Magnus Munck Af Rosenschold, Pavol Zlatoidsky
  • Metalloproteinase inhibitors
    Publication number: 20040116486
    Abstract: Compounds of the formula (I) useful as metalloproteinase inhibitors, especially as inhibitors of MMP12, wherein R5 is a monocyclic group.
    Type: Application
    Filed: January 12, 2004
    Publication date: June 17, 2004
    Inventors: Matti Lepisto, Magnus Munck Af Rosenschold
  • Metalloproteinase inhibitors
    Publication number: 20040110809
    Abstract: Compounds of the formula (I) useful as metalloproteinase inhibitors, especially as inhibitors of MMP12, wherein R5 is a bicyclic group.
    Type: Application
    Filed: January 12, 2004
    Publication date: June 10, 2004
    Inventors: Matti Lepisto, Magnus Munck Af Rosenschold
  • Metalloproteinase inhibitors
    Publication number: 20040106659
    Abstract: Compounds of the formula (I) wherein z —O— or —S—, useful as metalloproteinase inhibitors, especially as inhibitors of MMP12.
    Type: Application
    Filed: January 6, 2004
    Publication date: June 3, 2004
    Inventor: Magnus Munck Af Rosenschold